21 Jun Guidelines for Post Marketing Surveillance of Medicines and Health Products
Posted at 22:51h
in
To develop a medicine information data bank on the quality of medicines in circulation and disseminate such information to stakeholders involved in the medicines supply chain.
To promote communication and cooperation between stakeholders and partners involved in the medicines supply chain.
To identify possible causes of inferior quality of specific products to which patients are exposed…
Download latest version
Download archived version (DO NOT USE)
Download archived version (DO NOT USE)
Document Number:
SAHPGL-INSP-RC-01
Version:
3
Date Updated:
27/07/2023
File Type:
pdf
Category:
Guideline